This study was based on supplementation of NMN or knockdown the key biosynthetic enzyme NMNAT1 to regulate bi‐directionally cellular NAD+ levels and identified the NAD+‐consuming deacetylase, SIRT1, as an important factor associated with the capacity of NAD+ during LPS‐induced AKI. This evidence concerns the gene NMNAT1 and acute kidney injury.